CLIC1 as a Functional Gatekeeper of the Tumor Permissive State: Empirical Support for the NOAH6 Regulatory Model of Cancer and the Concept of P_state in Glioblastoma

In recent years, a significant shift has occurred in the understanding of tumor biology, especially glioblastoma. The traditional model according to which cancer is predominantly the result of the accumulation of genetic mutations is increasingly being supplemented by the concept of a dynamic regulatory tumor state. Ion channels, Ca²⁺ signaling, membrane potential, redox regulation, and functional signaling nodes that maintain the aggressive tumor phenotype are becoming central areas of interest. One of the most important proteins that has become highly relevant in this context is CLIC1 (Chloride Intracellular Channel 1). Although CLIC1 has been known for a long time, only recent research has shown that it is not merely a biomarker or passive companion of tumor activity, but a functional regulatory element required for maintaining the proliferative and invasive state of glioblastoma. Particularly important is the fact that CLIC1 acts as a metamorphic protein: under conditions of oxidative stress it transitions from a soluble cytosolic form into a transmembrane active form (tmCLIC1), thereby participating in the regulation of membrane potential and the Ca²⁺ microenvironment. Experimental models have shown that blocking or removing CLIC1 can dramatically reduce tumor proliferation, destabilize the signaling network, and in some models almost completely stop glioblastoma growth. This paper analyzes how these discoveries fit into the NOAH6 model, especially into the concept of P_state — a stabilized permissive runtime state that maintains the tumor runaway process. The key hypothesis of this paper is that a tumor is not merely the consequence of a static genetic mutation, but a metastable physiological state that must be continuously maintained through regulatory signaling nodes. Within this framework, CLIC1 appears as a local stabilizer of the metastable proliferative attractor state. The paper also analyzes why only in 2025–2026 did the full scientific valorization of the CLIC1 concept emerge, despite the fact that the protein has been known for decades. It is shown that only modern single-cell technologies, live-cell ion mapping, extracellular vesicle analysis, CRISPR approaches, and the shift toward network biology enabled the understanding of CLIC1 as a functional gatekeeper of the tumor system.